Zobrazeno 1 - 10
of 607
pro vyhledávání: '"E. Gremese"'
Publikováno v:
Reumatismo, Vol 76, Iss 3 (2024)
Objective. This paper aims to provide an overview of the use of treatments available for axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) during pregnancy and breastfeeding, according to current national recommendations and international
Externí odkaz:
https://doaj.org/article/c1081ea75d4b49a09233f218ac5bb08c
Case report: Dupilumab treatment improved type 2 disorders in a patient with IPEX syndrome diagnosis
Autor:
C. Caruso, L. Laterza, C. R. Settanni, S. Colantuono, C. Di Mario, B. Tolusso, F. Castrì, E. Gremese, F. Scaldaferri, A. Armuzzi, C. De Simone, K. Peris, A. Chiricozzi, A. Gasbarrini
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
We described a case of IPEX syndrome successfully controlled with dupilumab, an anti-IL4 receptor alpha subunit inhibitor. IPEX syndrome is a rare and generally fatal genetic disorder characterized by immune dysregulation, polyendocrinopathy and ente
Externí odkaz:
https://doaj.org/article/96e741e104df4a0583ef8abba24751dc
Autor:
C. Caruso, S. Colantuono, D. Pugliese, C. Di Mario, B. Tolusso, E. Gremese, G. Papparella, F. Castrì, A. Gasbarrini, A. Romano, A. Armuzzi
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 16, Iss 1, Pp 1-5 (2020)
Abstract Background Mepolizumab (MEP) is the first anti Interleukin (IL)-5 add-on therapy approved for the treatment of severe refractory eosinophilic asthma. Case presentation We describe here the case of a 49 years-old woman with Aspirin-exacerbate
Externí odkaz:
https://doaj.org/article/61a57094ea0d4007b5d8a9285db72428
Autor:
A. Manfredi, G. Cassone, S. Cerri, V. Venerito, A. L. Fedele, M. Trevisani, F. Furini, O. Addimanda, F. Pancaldi, G. Della Casa, R. D’Amico, R. Vicini, G. Sandri, P. Torricelli, I. Celentano, A. Bortoluzzi, N. Malavolta, R. Meliconi, F. Iannone, E. Gremese, F. Luppi, C. Salvarani, M. Sebastiani, on behalf of GISEA (Gruppo Italiano Studio Early Arthritis)
Publikováno v:
BMC Pulmonary Medicine, Vol 19, Iss 1, Pp 1-6 (2019)
Abstract Background Interstitial lung disease (ILD) is a severe systemic manifestation of rheumatoid arthritis (RA). High-resolution computed tomography (HRCT) represents the gold standard for the diagnosis of ILD, but its routine use for screening p
Externí odkaz:
https://doaj.org/article/911ae9207b9d4eeca950613e2567d296
Autor:
S.L. Bosello, M.S. Chimenti, P. Conigliaro, C. Iannuccelli, E. Gremese, F.R. Spinelli, M. Vadacca
Publikováno v:
Reumatismo, Vol 71, Iss 4 (2020)
Not available
Externí odkaz:
https://doaj.org/article/10808b00ab8740b79759a4fcd0ee8241
Publikováno v:
Reumatismo, Vol 65, Iss 2, Pp 75-78 (2013)
Inflammatory bowel disease (IBD) is commonly associated with peripheral inflammatory arthritis, and it has been estimated that as many as 12% of IBD patients report these manifestations. However, rheumatoid arthritis (RA) is rarely associated with ul
Externí odkaz:
https://doaj.org/article/e55118c5592a46779678e93b1ec3dfc1
Publikováno v:
Reumatismo, Vol 64, Iss 6, Pp 368-373 (2012)
Objective. Several studies underline the relevance of the genetic background for the response to therapy. We evaluated the relationship between the polymorphism of the HS1,2A enhancer, located in the 3’ regulatory region of the heavy immunoglobulin
Externí odkaz:
https://doaj.org/article/bb08af493f5d4ac3b4d7ff3265b561a4
Publikováno v:
Reumatismo, Vol 63, Iss 1, Pp 5-10 (2011)
Patients affected by acute coronary syndrome (ACS) or by chronic inflammatory musculoskeletal and connective tissue diseases (i.e. systemic sclerosis), often need antiaggregant therapy (ASA or Clopidogrel). The concomitant use of proton pump inhibito
Externí odkaz:
https://doaj.org/article/d0263f99da9049ab9404b0feaddc907d
Publikováno v:
Reumatismo, Vol 56, Iss 2 (2004)
Objective. Given the role of TNF-α in Rheumatoid Arthritis (RA) we decided to define the characteristics of the TNF- α synthesis by peripheral blood mononuclear cells (PBMNCs) obtained from active-aggressive RA patients giving a particular attentio
Externí odkaz:
https://doaj.org/article/177ee2af948a47778d43d48eacfeb1dd
Publikováno v:
Reumatismo, Vol 55, Iss 3 (2003)
Objective: To assess the agreement between presence and location of central nervous system (CNS) structural damage and neuropsychological performance. Methods: 21 unselected SLE patients underwent a 3 hours-long battery of neuropsychological tests sa
Externí odkaz:
https://doaj.org/article/6143ab5ed87a46fb9304efb333586f49